These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9782217)

  • 21. An evaluation of nebulized levalbuterol in stable COPD.
    Datta D; Vitale A; Lahiri B; ZuWallack R
    Chest; 2003 Sep; 124(3):844-9. PubMed ID: 12970007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bronchodilator efficacy of the fixed combination of ipratropium and albuterol compared to albuterol alone in moderate-to-severe persistent asthma.
    Gelb AF; Karpel J; Wise RA; Cassino C; Johnson P; Conoscenti CS
    Pulm Pharmacol Ther; 2008 Aug; 21(4):630-6. PubMed ID: 18403223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superiority of ipratropium plus albuterol over albuterol alone in the emergency department management of adult asthma: a randomized clinical trial.
    Lin RY; Pesola GR; Bakalchuk L; Morgan JP; Heyl GT; Freyberg CW; Cataquet D; Westfal RE
    Ann Emerg Med; 1998 Feb; 31(2):208-13. PubMed ID: 9472182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is oral theophylline effective in combination with both inhaled anticholinergic agent and inhaled beta 2-agonist in the treatment of stable COPD?
    Nishimura K; Koyama H; Ikeda A; Izumi T
    Chest; 1993 Jul; 104(1):179-84. PubMed ID: 8325065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness and acceptability of a domiciliary multidrug inhalation treatment in elderly patients with chronic airflow obstruction: metered dose inhaler versus jet nebulizer.
    Balzano G; Battiloro R; Biraghi M; Stefanelli F; Fuschillo S; Gaudiosi C; De Angelis E
    J Aerosol Med; 2000; 13(1):25-33. PubMed ID: 10947321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium.
    van Noord JA; de Munck DR; Bantje TA; Hop WC; Akveld ML; Bommer AM
    Eur Respir J; 2000 May; 15(5):878-85. PubMed ID: 10853852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma.
    Karpel JP; Schacter EN; Fanta C; Levey D; Spiro P; Aldrich T; Menjoge SS; Witek TJ
    Chest; 1996 Sep; 110(3):611-6. PubMed ID: 8797400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department.
    Rodrigo GJ; Rodrigo C
    Am J Respir Crit Care Med; 2000 Jun; 161(6):1862-8. PubMed ID: 10852758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The additive effect of theophylline on a high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPD.
    Nishimura K; Koyama H; Ikeda A; Sugiura N; Kawakatsu K; Izumi T
    Chest; 1995 Mar; 107(3):718-23. PubMed ID: 7874943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of bronchodilator effects of fenoterol/ipratropium bromide and salbutamol in patients with chronic obstructive lung disease.
    Imhof E; Elsasser S; Karrer W; Grossenbacher M; Emmons R; Perruchoud AP
    Respiration; 1993; 60(2):84-8. PubMed ID: 8341859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is an anticholinergic agent superior to a beta 2-agonist in improving dyspnea and exercise limitation in COPD?
    Blosser SA; Maxwell SL; Reeves-Hoche MK; Localio AR; Zwillich CW
    Chest; 1995 Sep; 108(3):730-5. PubMed ID: 7656624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of bronchodilators administered via aerochamber or a nebulizer on inspiratory lung function parameters.
    Ramlal SK; Visser FJ; Hop WC; Dekhuijzen PN; Heijdra YF
    Respir Med; 2013 Sep; 107(9):1393-9. PubMed ID: 23768736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does high dose ipratropium bromide added to salbutamol improve pulmonary function for patients with chronic obstructive airways disease in the emergency department?
    Koutsogiannis Z; Kelly AM
    Aust N Z J Med; 2000 Feb; 30(1):38-40. PubMed ID: 10800876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of ipratropium bromide and albuterol in chronic obstructive pulmonary disease: a three-center study.
    Braun SR; Levy SF
    Am J Med; 1991 Oct; 91(4A):28S-32S. PubMed ID: 1835292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bronchodilation and safety of supratherapeutic doses of salbutamol or ipratropium bromide added to single dose GSK961081 in patients with moderate to severe COPD.
    Norris V; Ambery C
    Pulm Pharmacol Ther; 2013 Oct; 26(5):574-80. PubMed ID: 23524017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective, comparative trial of standard and breath-actuated nebulizer: efficacy, safety, and satisfaction.
    Arunthari V; Bruinsma RS; Lee AS; Johnson MM
    Respir Care; 2012 Aug; 57(8):1242-7. PubMed ID: 22348319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of nebulized ipratropium in severely asthmatic children.
    Qureshi F; Zaritsky A; Lakkis H
    Ann Emerg Med; 1997 Feb; 29(2):205-11. PubMed ID: 9018183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Chest; 1995 Feb; 107(2):401-5. PubMed ID: 7842768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study.
    Make B; Hanania NA; ZuWallack R; Kalberg C; Emmett A; Brown CP; Knobil K
    Clin Ther; 2005 May; 27(5):531-42. PubMed ID: 15978302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.